Are BCAAs Mere Biomarkers of Diabetes?

Journal Title: Diabetes Research – Open Journal - Year 2017, Vol 3, Issue 1

Abstract

Branched-chain amino acids (BCAAs; ie. leucine, isoleucine, and valine) are essential amino acids we need to ingest through our diet.While circulating BCAA levels were first found to be elevated in obese individuals back in 1969 by Felig and colleagues,1 the potential role of BCAAs in obesity and diabetes development has been re-highlighted in the last decade. Using advanced metabolomic platforms, many independent investigators were able to reproduce the earlier finding and further demonstrate that not only plasma BCAAs, but also their partially oxidized intermediates such as α-keto acids and short-chain (C3-C5) acylcarnitines are increased in obese or insulin resistant/diabetic individuals, including Caucasians and Asians.2-9 Moreover, plasma BCAAs are found to be the earliest and the most predictive marker for future risk of diabetes,10 and elevated plasma leucine levels precede the development of fatty liver,11 suggesting that circulating leucine is a predictive marker of hepatic steatosis. Interestingly, plasma BCAAs and their derived short-chain acylcarnitines are effectively lowered by bariatric surgery in obese and/or diabetic individuals.5,8,12,13 Whether this normalized BCAA metabolism after RYGB surgery in morbidly obese patients contributes to improved insulin sensitivity and glycemic control or is just a secondary effect of the surgery needs to be examined further. Nonetheless, collectively these studies implicate a role of plasma BCAAs and their metabolites in the pathogenesis of insulin resistance and diabetes.

Authors and Affiliations

Andrew C. Shin

Keywords

Related Articles

NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation

Metaflammation is a metabolic inflammatory state characterized by chronic, lowgrade inflammatory response initiated by excess nutrients in metabolic cells.1 The inflammatory signaling conducted by the metabolic cell eve...

Videocapillaroscopy in Diabetes

Capillaroscopy is a method of recognized value in the study of morphological and functional abnormalities of the microcirculation. Its use in the clinical field dates from the early twentieth century,1 extending the cli...

Diabetes in the Northwest Territories

An estimated 2.7 million (7.6%) Canadians were living with diabetes in 2012.1 Internationally, Canada has the fourth highest rate of diabetes, behind Mexico, the United States and Portugal.2 The prevalence of diabetes...

Association of Total and Differential White Blood Cell Counts to Development of Type 2 Diabetes in Mexican Americans in Cameron County Hispanic Cohort

Objective: To evaluate the relationship between total and differential White Blood Cells (WBC) counts with time to transition to type 2 diabetes in Mexican Americans using prospective data from the Cameron County Hispani...

A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?

Aim: Current guidelines suggest pursuing optimal metabolic management ever since the onset of type 2 diabetes mellitus (T2DM). Nevertheless, over 50% Italian patients fail to meet expected metabolic targets. The aim of o...

Download PDF file
  • EP ID EP550197
  • DOI 10.17140/DROJ-3-e009
  • Views 107
  • Downloads 0

How To Cite

Andrew C. Shin (2017). Are BCAAs Mere Biomarkers of Diabetes?. Diabetes Research – Open Journal, 3(1), 4-8. https://europub.co.uk/articles/-A-550197